- Home
- PKBK vs ABEO Comparison
PKBK vs ABEO Comparison
Compare PKBK & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PKBK | ABEO |
|---|---|---|
| Founded | 1999 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 353.1M | 320.3M |
| IPO Year | 2005 | 2005 |
Fundamental Metrics
Financial Performance| Metric | PKBK | ABEO |
|---|---|---|
| Price | $32.77 | $6.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 61.0K | ★ 1.4M |
| Earning Date | 04-17-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.40% | N/A |
| EPS Growth | 39.21 | ★ 165.16 |
| EPS | ★ 0.99 | N/A |
| Revenue | N/A | ★ $2,998,000.00 |
| Revenue This Year | N/A | $1,024.31 |
| Revenue Next Year | N/A | $145.42 |
| P/E Ratio | $32.57 | ★ N/A |
| Revenue Growth | N/A | ★ 258.18 |
| 52 Week Low | $19.71 | $4.00 |
| 52 Week High | $34.00 | $7.54 |
Technical Indicators
Market Signals| Indicator | PKBK | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 56.32 | 76.01 |
| Support Level | $29.95 | $4.85 |
| Resistance Level | $34.00 | N/A |
| Average True Range (ATR) | 0.72 | 0.30 |
| MACD | -0.07 | 0.13 |
| Stochastic Oscillator | 54.91 | 88.70 |
Price Performance
Historical ComparisonAbout PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending, among others. The company operates one reportable segment of business, community banking.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.